VORA360 Performance Care page featuring CJC-1295 Ipamorelin, MOTS-C, Tesamorelin, and IGF-LR3 performance products VORA360 Home Explore Care How It Works About Resources Get Started Back to Home Weight & Health Recovery Performance Longevity Hair & Skin Mind & Sleep Sexual Wellness See If I Qualify Performance Products

Clinician-Directed Care

Work with experienced providers who understand your goals and create a plan built around you.

Personalized Over Time

Your protocol evolves with your progress, lab work, and goals — because your journey isn’t static.

Progress, Not Pressure

Sustainable performance is about consistency, support, and long-term health — not quick fixes.

Performance Care through VORA360

Explore a clinician-guided approach to performance goals, recovery and sustainable routines. Your health history, individual needs and clinician judgment shape the next step.

Sustainable progress starts with your goals

Tell your clinician about the activities, routines and performance goals that matter to you. Any plan depends on your individual evaluation and can evolve with your progress and clinician guidance.

How to get started

  1. Complete a private intake with your goals and health history.
  2. An independent licensed clinician reviews your information and determines whether treatment is appropriate.
  3. If eligible, follow the personalized plan and any follow-up guidance provided by your clinician.

Start your private intake or visit the patient portal if you already have an account.

Performance Care: questions and answers

Is VORA360 performance care a one-size-fits-all plan?

No. A licensed clinician reviews your health information and goals before considering a personalized plan. An intake does not guarantee eligibility, treatment or a prescription.

Who makes treatment decisions?

Independent licensed clinicians determine eligibility and treatment. VORA RX, INC. provides technology, coordination and membership services; it is not a healthcare provider or pharmacy and does not control clinical decisions.

Is a prescription or a result guaranteed?

No. Treatment is available only when clinically appropriate and permitted by applicable law. Availability varies by location, clinician, pharmacy and patient eligibility. Compounded medications are not FDA-approved. Individual results vary.

VORA360 facilitates access to independent licensed clinicians and care partners. Prescription treatment requires clinician evaluation. Availability and eligibility vary; treatment and results are not guaranteed. Compounded medications are not FDA-approved. Review the telehealth consent, privacy policy and terms of service.

Explore connected care pathways

Coming soon

Performance care

CJC-1295 / Ipamorelin

CJC-1295 / Ipamorelin vial mockup

A peptide combination discussed in connection with growth-hormone signaling. Human evidence is limited, and a clinician must consider medical history, potential risks and appropriate alternatives.

Your next stepWe’re preparing this screening pathway. Leave your details for product launch updates while the form is being completed.

Countdown to the planned screening launch

—Days
—Hours
—Minutes
—Seconds

Target: October 16, 2026. Timing and availability may change.

Join the launch list. It takes about 20 seconds.

Explore available care

Educational information only. Availability and any treatment depend on clinical review. A screening form does not guarantee a prescription.

Coming soon

Performance care

MOTS-C

MOTS-C vial mockup

A mitochondria-derived peptide studied in cellular energy and metabolic signaling. Much of the evidence remains experimental; research findings are not a promise of improved athletic performance.

Your next stepWe’re preparing this screening pathway. Leave your details for product launch updates while the form is being completed.

Countdown to the planned screening launch

—Days
—Hours
—Minutes
—Seconds

Target: October 16, 2026. Timing and availability may change.

Join the launch list. It takes about 20 seconds.

Explore available care

Educational information only. Availability and any treatment depend on clinical review. A screening form does not guarantee a prescription.

Coming soon

Performance care

Tesamorelin

Tesamorelin vial mockup

A growth-hormone-releasing factor analog. FDA-approved tesamorelin has a specific indication for excess abdominal fat in adults with HIV-associated lipodystrophy; it is not approved for general weight-loss management.

Your next stepWe’re preparing this screening pathway. Leave your details for product launch updates while the form is being completed.

Countdown to the planned screening launch

—Days
—Hours
—Minutes
—Seconds

Target: October 16, 2026. Timing and availability may change.

Join the launch list. It takes about 20 seconds.

Explore available care

Educational information only. Availability and any treatment depend on clinical review. A screening form does not guarantee a prescription.

Coming soon

Performance care

IGF-LR3

IGF-LR3 vial mockup

A modified form of insulin-like growth factor discussed in growth-signaling research. It is not an established general fitness treatment, and clinical evidence, safety and eligibility require careful review.

Your next stepWe’re preparing this screening pathway. Leave your details for product launch updates while the form is being completed.

Countdown to the planned screening launch

—Days
—Hours
—Minutes
—Seconds

Target: October 16, 2026. Timing and availability may change.

Join the launch list. It takes about 20 seconds.

Explore available care

Educational information only. Availability and any treatment depend on clinical review. A screening form does not guarantee a prescription.